Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 122

    1.

    Herpes simplex and eosinophilic oesophagitis: the chicken or the egg?

    Squires KA, Cameron DJ, Oliver M, da Fonseca Junqueira JC.

    J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):246-50. No abstract available. PMID: 19561550 [PubMed - indexed for MEDLINE]Related articles

    2.

    A novel codon insert in protease of clade B HIV type 1.

    Jordan PS, Poon A, Eron J, Squires K, Ignacio C, Richman DD, Smith DM.

    AIDS Res Hum Retroviruses. 2009 May;25(5):547-50.PMID: 19397401 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.

    Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR.

    J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):274-82.PMID: 19387354 [PubMed - indexed for MEDLINE]Related articles

    4.

    HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians.

    Lubinski C, Aberg J, Bardeguez AD, Elion R, Emmanuel P, Kuritzkes D, Saag M, Squires KE, Weddle A, Rainey J, Zerehi MR, Ralston JF, Fleming DA, Bronson D, Cooke M, Cutler C, Ejnes Y, Gluckman R, Liebow M, Musana K, Mayer ME, Purtle MW, Reynolds PP, Viswanathan L, Weiss KB, Yehia B.

    Clin Infect Dis. 2009 May 15;48(10):1335-44. No abstract available. PMID: 19385087 [PubMed - indexed for MEDLINE]Related articles

    5.

    Multidrug-experienced HIV-1-infected women demonstrated similar virological and immunological responses to tipranavir/ritonavir compared with men.

    Walmsley SL, Squires K, Weiss L, Easterbrook P, Orani A, Kraft M, Scherer J.

    AIDS. 2009 Jan 28;23(3):429-31.PMID: 19114862 [PubMed - indexed for MEDLINE]Related articles

    6.

    Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

    Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH; ACTG 5152s Study Team.

    J Am Coll Cardiol. 2008 Aug 12;52(7):569-76.PMID: 18687253 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    HIV Infection in Women: Do Sex and Gender Matter?

    Belden KA, Squires KE.

    Curr Infect Dis Rep. 2008 Sep;10(5):423-31.PMID: 18687207 [PubMed - in process]Related articles

    8.

    First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America.

    Young B, Squires K, Patel P, Dejesus E, Bellos N, Berger D, Sutherland-Phillips DH, Liao Q, Shaefer M, Wannamaker P.

    AIDS. 2008 Aug 20;22(13):1673-5.PMID: 18670229 [PubMed - indexed for MEDLINE]Related articles

    9.

    State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.

    Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH.

    Circulation. 2008 Jul 8;118(2):198-210. Epub 2008 Jun 19. No abstract available. Erratum in: Circulation. 2008 Aug 5;118(6):e109. PMID: 18566320 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Screening and assessment of coronary heart disease in HIV-infected patients.

    Hsue PY, Squires K, Bolger AF, Capili B, Mensah GA, Temesgen Z, Wanke CA, Wohl DA; Working Group 4.

    Circulation. 2008 Jul 8;118(2):e41-7. Epub 2008 Jun 19. No abstract available. PMID: 18566317 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization.

    Sansom SL, Anthony MN, Garland WH, Squires KE, Witt MD, Kovacs Andrea A, Larsen RA, Valencia R, Pals SL, Hader S, Weidle PJ, Wohl AR.

    AIDS Patient Care STDS. 2008 Feb;22(2):131-8.PMID: 18260804 [PubMed - indexed for MEDLINE]Related articles

    12.

    Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.

    Demeter LM, DeGruttola V, Lustgarten S, Bettendorf D, Fischl M, Eshleman S, Spreen W, Nguyen BY, Koval CE, Eron JJ, Hammer S, Squires K.

    HIV Clin Trials. 2008 Jan-Feb;9(1):11-25.PMID: 18215978 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Gender differences in the diagnosis and treatment of HIV.

    Squires KE.

    Gend Med. 2007 Dec;4(4):294-307.PMID: 18215722 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.

    Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H.

    Nat Med. 2007 Oct;13(10):1241-7. Epub 2007 Sep 30.PMID: 17906637 [PubMed - indexed for MEDLINE]Related articles

    15.

    Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients.

    Campo RE, Narayanan S, Clay PG, Dehovitz J, Johnson D, Jordan W, Squires KE, Sajjan SG, Markson LE.

    AIDS Patient Care STDS. 2007 May;21(5):329-38.PMID: 17518525 [PubMed - indexed for MEDLINE]Related articles

    16.

    Women and HIV: a population at risk.

    Squires KE.

    Res Initiat Treat Action. 2007 Winter;12(2):18-20. No abstract available. PMID: 17489118 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.

    Gulick RM, Lalama CM, Ribaudo HJ, Shikuma CM, Schackman BR, Schouten J, Squires KE, Koletar SL, Pilcher CD, Reichman RC, Klingman KL, Kuritzkes DR.

    AIDS. 2007 Apr 23;21(7):813-23.PMID: 17415036 [PubMed - indexed for MEDLINE]Related articles

    18.

    The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California.

    Garland WH, Wohl AR, Valencia R, Witt MD, Squires K, Kovacs A, Larsen R, Potterat N, Anthony MN, Hader S, Weidle PJ.

    AIDS Care. 2007 Feb;19(2):159-67.PMID: 17364394 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.

    Kuritzkes DR, Ribaudo HJ, Squires KE, Koletar SL, Santana J, Riddler SA, Reichman R, Shikuma C, Meyer WA 3rd, Klingman KL, Gulick RM; ACTG A5166s Protocol Team.

    J Infect Dis. 2007 Apr 15;195(8):1169-76. Epub 2007 Mar 6.PMID: 17357053 [PubMed - indexed for MEDLINE]Related articles

    20.

    Occult hepatic opportunistic infection (OI) and highly active antiretroviral therapy (HAART) induced immune reconstitution: an important cause of jaundice in a patient with AIDS.

    Verma S, Bhakta H, Nowain A, Kanel G, Squires K.

    AIDS Res Hum Retroviruses. 2006 Oct;22(10):1052-3. No abstract available. PMID: 17067277 [PubMed - indexed for MEDLINE]Related articles

    21.

    Carbon sequestration via aqueous olivine mineral carbonation: role of passivating layer formation.

    Béarat H, McKelvy MJ, Chizmeshya AV, Gormley D, Nunez R, Carpenter RW, Squires K, Wolf GH.

    Environ Sci Technol. 2006 Aug 1;40(15):4802-8.PMID: 16913142 [PubMed - indexed for MEDLINE]Related articles

    22.

    Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

    Gulick RM, Ribaudo HJ, Shikuma CM, Lalama C, Schackman BR, Meyer WA 3rd, Acosta EP, Schouten J, Squires KE, Pilcher CD, Murphy RL, Koletar SL, Carlson M, Reichman RC, Bastow B, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team.

    JAMA. 2006 Aug 16;296(7):769-81.PMID: 16905783 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Editorial comment: women and HIV--a population at risk.

    Squires KE.

    AIDS Read. 2006 Jul;16(7):374-5. No abstract available. PMID: 16874917 [PubMed - indexed for MEDLINE]Related articles

    24.

    A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.

    Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, Larsen R, Hader S, Anthony MN, Weidle PJ.

    Clin Infect Dis. 2006 Jun 1;42(11):1619-27. Epub 2006 Apr 28.PMID: 16652320 [PubMed - indexed for MEDLINE]Related articles

    26.

    Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?

    Verma S, Wang CH, Govindarajan S, Kanel G, Squires K, Bonacini M.

    Clin Infect Dis. 2006 Jan 15;42(2):262-70. Epub 2005 Dec 2.PMID: 16355339 [PubMed - indexed for MEDLINE]Related articles

    27.

    The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.

    Wohl DA, Kendall MA, Owens S, Holland G, Nokta M, Spector SA, Schrier R, Fiscus S, Davis M, Jacobson MA, Currier JS, Squires K, Alston-Smith B, Andersen J, Freeman WR, Higgins M, Torriani FJ; ACTG 379 Study Team.

    HIV Clin Trials. 2005 May-Jun;6(3):136-46.PMID: 16192248 [PubMed - indexed for MEDLINE]Related articles

    28.

    Severe cholestatic liver injury days after initiating antiretroviral therapy in a patient with AIDS: drug toxicity or immune reconstitution inflammatory syndrome?

    Verma S, Bhakta H, Nowain A, Pais S, Kanel G, Squires K.

    Dig Dis Sci. 2005 Oct;50(10):1813-7. No abstract available. PMID: 16187179 [PubMed - indexed for MEDLINE]Related articles

    29.

    Editorial comment: HIV-infected women require a range of specialized services.

    Squires KE.

    AIDS Read. 2005 Aug;15(8):426. No abstract available. PMID: 16114128 [PubMed - indexed for MEDLINE]Related articles

    30.

    Gender-specific considerations in the antiretroviral management of HIV-infected women.

    Clark RA, Squires KE.

    Expert Rev Anti Infect Ther. 2005 Apr;3(2):213-27. Review.PMID: 15918779 [PubMed - indexed for MEDLINE]Related articles

    31.

    Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.

    Cahn PE, Gatell JM, Squires K, Percival LD, Piliero PJ, Sanne IA, Shelton S, Lazzarin A, Odeshoo L, Kelleher TD, Thiry A, Giordano MD, Schnittman SM.

    J Int Assoc Physicians AIDS Care (Chic Ill). 2004 Jul-Sep;3(3):92-8. Review.PMID: 15573713 [PubMed - indexed for MEDLINE]Related articles

    32.

    Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

    Squires K, Lazzarin A, Gatell JM, Powderly WG, Pokrovskiy V, Delfraissy JF, Jemsek J, Rivero A, Rozenbaum W, Schrader S, Sension M, Vibhagool A, Thiry A, Giordano M.

    J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1011-9.PMID: 15247553 [PubMed - indexed for MEDLINE]Related articles

    33.

    Incidence and risk factors for sexually transmitted infections among women in an Alabama HIV clinic.

    Monteiro CA, Bachmann LH, Desmond RA, Squires KE, Vermund SH, Hook EW, Schwebke JR, Hoesley CJ.

    AIDS Res Hum Retroviruses. 2004 Jun;20(6):577-83.PMID: 15242532 [PubMed - indexed for MEDLINE]Related articles

    34.

    The feasibility of a community-based directly administered antiretroviral therapy program.

    Wohl AR, Garland WH, Squires K, Witt M, Larsen R, Kovacs A, Hader S, Weidle PJ.

    Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S388-92.PMID: 15156427 [PubMed - indexed for MEDLINE]Related articles

    35.

    Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

    Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA 3rd, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group Study A5095 Team.

    N Engl J Med. 2004 Apr 29;350(18):1850-61.PMID: 15115831 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).

    Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B; AIDS Clinical Trials Group 248 Study Team.

    J Acquir Immune Defic Syndr. 2004 May 1;36(1):576-87.PMID: 15097300 [PubMed - indexed for MEDLINE]Related articles

    37.

    Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

    van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JM; 2NN Study team.

    Lancet. 2004 Apr 17;363(9417):1253-63.PMID: 15094269 [PubMed - indexed for MEDLINE]Related articles

    38.

    A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

    Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V; ACTG 372B/D Study Team.

    Antivir Ther. 2003 Dec;8(6):507-18. No abstract available. PMID: 14760884 [PubMed - indexed for MEDLINE]Related articles

    39.

    Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.

    Hirsch MS, Steigbigel RT, Staszewski S, McMahon D, Fischl MA, Hirschel B, Squires K, DiNubile MJ, Harvey CM, Chen J, Leavitt RY; Protocol 039 Study Group.

    Clin Infect Dis. 2003 Oct 15;37(8):1119-24. Epub 2003 Sep 18.PMID: 14523778 [PubMed - indexed for MEDLINE]Related articles

    40.

    Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.

    Squires K, Pozniak AL, Pierone G Jr, Steinhart CR, Berger D, Bellos NC, Becker SL, Wulfsohn M, Miller MD, Toole JJ, Coakley DF, Cheng A; Study 907 Team.

    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):313-20.PMID: 12965939 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care.

    Cohen C, Elion RA, Frank I, Kloser P, Sherer R, Squires KE, Steinhart C, Tebas P; Advisory Committee of the International Association of Physicians in AIDS Care.

    J Int Assoc Physicians AIDS Care (Chic Ill). 2002 Oct-Dec;1(4):141-5. Review.PMID: 12942673 [PubMed - indexed for MEDLINE]Related articles

    42.

    Risk of opportunistic infection in the HAART era among HIV-infected Latinos born in the United States compared to Latinos born in Mexico and Central America.

    Wohl AR, Lu S, Turner J, Kovacs A, Witt M, Squires K, Towner W, Beer V.

    AIDS Patient Care STDS. 2003 Jun;17(6):267-75.PMID: 12880490 [PubMed - indexed for MEDLINE]Related articles

    43.

    Treating HIV infection and AIDS in women.

    Squires KE.

    AIDS Read. 2003 May;13(5):228-34, 239-40. Review. No abstract available. PMID: 12800826 [PubMed - indexed for MEDLINE]Related articles

    44.

    Serum albumin is a powerful predictor of survival among HIV-1-infected women.

    Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, Williams C, Goldwasser P, Anastos K.

    J Acquir Immune Defic Syndr. 2003 May 1;33(1):66-73.PMID: 12792357 [PubMed - indexed for MEDLINE]Related articles

    45.

    Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects.

    DiCenzo R, Forrest A, Squires KE, Hammer SM, Fischl MA, Wu H, Cha R, Morse GD; Adult AIDS Clinical Trials Group Protocol 368/886 Study Team.

    Antimicrob Agents Chemother. 2003 Jun;47(6):1929-35.PMID: 12760869 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Current management challenges in HIV: antiretroviral resistance.

    Kuritzkes DR, Boyle BA, Gallant JE, Squires KE, Zolopa A.

    AIDS Read. 2003 Mar;13(3):133-5, 138-42.PMID: 12728868 [PubMed - indexed for MEDLINE]Related articles

    47.

    A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bánhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM.

    AIDS. 2003 May 2;17(7):987-99.PMID: 12700448 [PubMed - indexed for MEDLINE]Related articles

    48.

    Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.

    Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, Miotti P.

    J Infect Dis. 2003 Jan 15;187(2):194-205. Epub 2003 Jan 6.PMID: 12552444 [PubMed - indexed for MEDLINE]Related articles

    49.

    A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level.

    Wright PW, Hoesley CJ, Squires KE, Croom-Rivers A, Weiss HL, Gnann JW Jr.

    Clin Infect Dis. 2003 Jan 15;36(2):207-11. Epub 2003 Jan 6.PMID: 12522754 [PubMed - indexed for MEDLINE]Related articles

    50.

    Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.

    Sanne I, Piliero P, Squires K, Thiry A, Schnittman S; AI424-007 Clinical Trial Group.

    J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):18-29.PMID: 12514410 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...